HOME >> MEDICINE >> NEWS
Research guides medication choices for young Asthma patients

New research should help physicians choose effective asthma medications tailored to the characteristics of their individual patients. Researchers at National Jewish Medical and Research Center and their colleagues in the National Heart, Lung and Blood Institute's (NHLBI) Childhood Asthma Research and Education Network identify in the February Journal of Allergy and Clinical Immunology specific characteristics in children associated with better responses to inhaled steroids and to leukotriene receptor antagonists. The research builds on a trend to use scientific evidence, rather than trial-and-error, to customize medication choices for specific individuals.

"We found that responses to these two medications varied considerably from child to child," said Stanley Szefler, M.D., lead author and Professor of Pediatrics at National Jewish Medical and Research Center. "Young asthma patients with low pulmonary function or evidence of allergic inflammation are most likely to respond well to inhaled corticosteroids and should try those first. Other young patients can try either the inhaled steroids or leukotriene receptor antagonists first. Patients under 10 years of age who have had asthma for a short time may respond well to the leukotriene receptor antagonists." Inhaled corticosteroids are broadly acting anti-inflammatory medications that are applied directly to the airways by breathing them in.

Leukotriene receptor antagonists, taken in pill form, act systemically to block substances call leukotrienes, which are associated with inflammation and allergic reactions. Both medications are considered effective, but inhaled steroids are currently the preferred long-term therapy for persistent asthma.

"If we can pinpoint in advance which children will do better with a certain type of therapy, we can improve their lives more quickly and save them the risk of trying medications that are less effective for them," noted James Kiley, Ph.D., director of the N
'"/>

Contact: William Allstetter
allstetterw@njc.org
303-398-1002
National Jewish Medical and Research Center
1-Feb-2005


Page: 1 2 3

Related medicine news :

1. Researchers search for first sign of congestive heart failure
2. Research offers hope of new treatments for liver damage
3. Research suggests possible blood test for multiple sclerosis
4. Researchers say breast cancer in Africa may provide clues to the disease in African-Americans
5. 2005 Award for Basic Research in Biological Mineralization
6. 2005 Craniofacial Biology Research Award
7. 2005 Research in Dental Caries Award
8. 2005 Research in Prosthodontics and Implants Award
9. 2005 Basic Research in Periodontal Disease Award
10. 2005 Research in Oral Biology Award
11. 2005 Pulp Biology Research Award

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... ... October 13, 2017 , ... ... Hannah Randall, PharmD ‘17, and Jennifer Huggins, PharmD ’17, along with clinical ... the primary prevention of cardiovascular diseases during the 15th Annual Women’s Health ...
(Date:10/13/2017)... ... 13, 2017 , ... Apple Rehab Shelton Lakes , which specializes in ... the facility as part of a disaster drill on October 3rd. , Apple Rehab ... City Emergency Manager, as well as the Connecticut Long Term Care Mutual Aid ...
(Date:10/13/2017)... BASKING RIDGE, N.J. (PRWEB) , ... October 13, 2017 , ... ... second annual Holly Day Market. Featuring a collection of specialty vendors and unique items ... myriad of personalized and quality-focused health and wellness services offered by the VNA. ...
(Date:10/13/2017)... ... ... Global Healthcare Management’s 4th Annual Kids Fun Run brought out many kids this ... by Global Healthcare Management’s CEO, Jon Letko, is aimed at getting kids excited about ... ages; it is a non-competitive, non-timed event, which is all about having fun and ...
(Date:10/13/2017)... , ... October 13, 2017 , ... ... be giving viewers the lowdown on sciatica in a new episode of "Success ... focuses on current events and innovation and investigates each subject in-depth with passion ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... Diplomat Pharmacy, Inc. (NYSE: DPLO ... LLC , and named its founder as Diplomat,s chief ... Tennessee , will operate under Diplomat subsidiary ... offerings for health care partners to include IT outsourcing, ... "In an interoperable world, technology delivers comprehensive insight ...
(Date:10/2/2017)... announces the European launch of their new low volume, high throughput ... Cambridge, U.K on October 4th. The new ... unprecedented speed and sensitivity while using far less sample volume through ... ... ...
(Date:9/28/2017)... , Sept. 28, 2017 Cohen Veterans Bioscience ... the use of wearable and home sensors for real-time ... Early Signal Foundation, a nonprofit organization focused on disruptive ... provide an affordable analytical system to record and integrate ... ...
Breaking Medicine Technology:
Cached News: